Elan Seeks Arbitration With Pfizer Over Alzheimer Research
Irish drug maker Elan is seeking binding arbitration in a dispute with Pfizer over research into treating Alzheimer's disease, the company said Friday....To view the full article, register now.
Already a subscriber? Click here to view full article